Aged
Aged, 80 and over
Humans
*Lymphatic Irradiation
Male
Middle Aged
Neoplasm Staging
Pelvis
Prospective Studies
Prostatic Neoplasms/mortality/*pathology/*radiotherapy
Radiotherapy Dosage
Survival Rate
Treatment Outcome
